Haemophilia prophylactic treatment in Spain

被引：4
|
作者：
Tusell, J [1 ]
Cid, AR [1 ]
Sosa, R [1 ]
Villar, A [1 ]
Lucia, JF [1 ]
机构：
[1] Hosp Valle De Hebron, Barcelona 08035, Spain
来源：
HAEMOPHILIA | 2002年 / 8卷 / 05期
关键词：
D O I：
10.1046/j.1365-2516.2002.00657.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：729 / 730
页数：2
相关论文
共 50 条
  • [21] Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden
    Carlsson, KS
    Höjgård, S
    Lindgren, A
    Lethagen, S
    Schulman, S
    Glomstein, A
    Tengborn, L
    Berntorp, E
    Lindgren, B
    HAEMOPHILIA, 2004, 10 (05) : 515 - 526
  • [22] Achieving self-management of prophylactic treatment in adolescents: The case of haemophilia
    Schrijvers, Liesbeth
    Beijlevelt-Van der Zande, Marlene
    Peters, Marjolein
    Lock, Janske
    Cnossen, Marjon
    Schuurmans, Marieke
    Fischer, Kathelijn
    PATIENT EDUCATION AND COUNSELING, 2016, 99 (07) : 1179 - 1183
  • [23] Modelling lifelong effects of different prophylactic treatment strategies for severe haemophilia A
    Fischer, K.
    Lewandowski, D.
    Janssen, M. P.
    HAEMOPHILIA, 2016, 22 (05) : E375 - E382
  • [24] COST IMPACT OF A NOVEL PROPHYLACTIC TREATMENT FOR HAEMOPHILIA A PATIENTS WITH INHIBITORS IN THE UK
    Roberts, G.
    Chu, P.
    Hampton, R.
    VALUE IN HEALTH, 2017, 20 (09) : A551 - A551
  • [25] Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A
    Bjorkman, S.
    HAEMOPHILIA, 2010, 16 (04) : 597 - 605
  • [26] To explore the underlying reason for non-adherence to prophylactic treatment in adolescents with haemophilia
    Hoefnagels, J. W.
    Kars, M. C.
    Fischer, K.
    Schuurmans, M. J.
    Schrijvers, L. H.
    HAEMOPHILIA, 2018, 24 : 12 - 13
  • [27] Prophylactic Treatment of Severe Haemophilia A Patients with Inhibitors to FVIII with Peglip-FVIII
    Timofeeva, Margarita
    Zozulya, Nadezhda I.
    Pospelova, Tatiana
    Kosinova, Marina V.
    Kurtov, Igor
    Tuddenham, Edward
    Ling, Gavin
    BLOOD, 2021, 138
  • [28] Effects of prophylactic treatment regimens in children with severe haemophilia: a comparison of different strategies
    van den Berg, HM
    Fischer, K
    van der Bom, JG
    Roosendaal, G
    Mauser-Bunschoten, EP
    HAEMOPHILIA, 2002, 8 : 43 - 46
  • [29] Long-term outcome of individualized prophylactic treatment of children with severe haemophilia
    van den Berg, HM
    Fischer, K
    Mauser-Bunschoten, EP
    Beek, FJA
    Roosendaal, G
    van der Bom, JG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 561 - 565
  • [30] When should prophylactic treatment in patients with haemophilia A and B start? - The German experience
    Kreuz, W
    Escuriola-Ettingshausen, C
    Funk, M
    Schmidt, H
    Kornhuber, B
    HAEMOPHILIA, 1998, 4 (04) : 413 - 417
12345